Your browser doesn't support javascript.
loading
Starting the Discussion: A Call to Enhance Care for People With Stimulant Use Disorder.
Alves, Justin; Rust, Victoria; Baldwin, Marielle; Puleikis, Logan; Claude, Ann; Brett, Meghan; LaBelle, Colleen T; Ventura, Alicia S.
Afiliação
  • Alves J; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA.
  • Rust V; General Internal Medicine, Boston Medical Center, Boston, MA, USA.
  • Baldwin M; Clinical Addiction Research and Education Unit, Section of General Internal Medicine, Boston Medical Center, Boston, MA, USA.
  • Puleikis L; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA.
  • Claude A; General Internal Medicine, Boston Medical Center, Boston, MA, USA.
  • Brett M; Grayken Center for Addiction Medicine, Boston Medical Center, Boston, MA, USA.
  • LaBelle CT; Boston University School of Medicine, Boston, MA, USA.
  • Ventura AS; Department of Family Medicine, Boston Medical Center, Boston, MA, USA.
Subst Abus ; 44(3): 115-120, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37728086
ABSTRACT
Stimulant use disorder (StUD) significantly contributes to substance-related morbidity and mortality in the United States. Overshadowed by the country's focus on opioid-related overdose deaths, stimulant and stimulant/opioid overdose deaths have increased dramatically over the last decade. Many individuals who use stimulants illicitly or have StUD have multiple, intersecting stigmatized characteristics which exacerbate existing barriers and create new obstacles to attaining addiction treatment. Illicit stimulant use, StUD, and stimulant-related overdose disproportionately impact minoritized racial and gender, and sexuality diverse groups. Historically, people who use illicit stimulants and those with StUD have been highly stigmatized, criminalized, and overly ignored by health care providers, policymakers, and the public compared to people who use other drugs and alcohol. As a result, most people needing treatment for StUD do not receive it. This is partly due to the lack of evidence-based treatment for StUD, which has resulted in few programs specializing in the care of people with StUD. The lack of available treatment is compounded by high rates of StUD in marginalized groups already reluctant to engage with the health care system. As health care professionals, we can improve outcomes for people with StUD by changing how we talk about, document, and respond to illicit stimulant use, related characteristics, behaviors, and social and structural determinants of health. To do this, we must seek to understand the lived realities of people with StUD and illicit stimulant use and use this knowledge to amend existing models of care.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2023 Tipo de documento: Article